Terry L Bowlin

Title: Innovations and Contributions of Terry L Bowlin

Introduction

Terry L Bowlin is a notable inventor based in Maineville, OH (US), recognized for his significant contributions to the field of therapeutics and viral infection prevention. With a total of 12 patents to his name, Bowlin has made strides in developing innovative solutions for combating viral infections.

Latest Patents

Among his latest patents is the invention titled "Broad spectrum inhibitors of filoviruses." This invention focuses on creating therapeutics and prophylactics aimed at treating and preventing filovirus infections in humans and other mammals. The patent discloses a new class of small molecules that inhibit the interaction of filovirus glycoprotein with the host receptor Niemann-Pick C1 protein, effectively blocking the infection of host cells by filoviruses. Another significant patent is "Inhibitors of viral entry into mammalian cells," which involves the development of compounds and methods to inhibit viral infections in mammals. This invention utilizes a pseudotype virus for high throughput assays to identify nonpeptidic small molecule inhibitors that prevent viral entry into host cells.

Career Highlights

Terry L Bowlin has had a distinguished career, working with prominent companies such as Merrell Dow Pharmaceuticals and Merrell Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Bowlin has collaborated with notable colleagues, including Nellikunja J Prakash and Sai P Sunkara. These collaborations have fostered innovation and the sharing of ideas in the field of viral therapeutics.

Conclusion

Terry L Bowlin's contributions to the field of viral infection prevention and therapeutics are commendable. His innovative patents and collaborations highlight his dedication to advancing medical science and improving public health.